ADENOVIRUS VECTORS FOR IMMUNOTHERAPY

Details for Australian Patent Application No. 2003228792 (hide)

Owner AVIOR THERAPEUTICS, INC.

Inventors MI, Jie; LIEBER, Andre

Pub. Number AU-A-2003228792

PCT Number PCT/US03/13560

PCT Pub. Number WO2003/093455

Priority 60/376,498 30.04.02 US

Filing date 30 April 2003

Wipo publication date 17 November 2003

International Classifications

C12N 005/02 Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 007/00 Viruses, e.g. bacteriophages

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 021/06 Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/376,498 30.04.02 US

8 January 2004 Application Open to Public Inspection

  Published as AU-A-2003228792

20 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228793-Smart Pro-Drugs of Serine Protease Inhibitors

2003228791-CERIUM-MODIFIED DOPED STRONTIUM TITANATE COMPOSITION FOR SOLID OXIDE FUEL CELL ANODES AND ELECTRODES FOR OTHER ELECTROCHEMICAL DEVICES